Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Nurix Therapeutics Inc’s stock clocked out at $20.66, down -3.32% from its previous closing price of $21.37. In other words, the price has decreased by -$3.32 from its previous closing price. On the day, 0.96 million shares were traded. NRIX stock price reached its highest trading level at $22.11 during the session, while it also had its lowest trading level at $20.25.
Ratios:
To gain a deeper understanding of NRIX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.28 and its Current Ratio is at 5.28. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on December 06, 2024, initiated with a Outperform rating and assigned the stock a target price of $35.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $35.
On October 11, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $41.Jefferies initiated its Buy rating on October 11, 2024, with a $41 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 02 ’24 when Ring Christine sold 5,760 shares for $21.73 per share. The transaction valued at 125,155 led to the insider holds 28,084 shares of the business.
CHRISTINE RING bought 5,760 shares of NRIX for $127,354 on Dec 02 ’24. On Nov 04 ’24, another insider, Ring Christine, who serves as the Chief Legal Officer of the company, sold 3,290 shares for $25.00 each. As a result, the insider received 82,250 and left with 28,084 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRIX now has a Market Capitalization of 1463478016 and an Enterprise Value of 1042568576. For the stock, the TTM Price-to-Sale (P/S) ratio is 27.63 while its Price-to-Book (P/B) ratio in mrq is 3.68. Its current Enterprise Value per Revenue stands at 18.477 whereas that against EBITDA is -5.593.
Stock Price History:
Over the past 52 weeks, NRIX has reached a high of $29.56, while it has fallen to a 52-week low of $7.65. The 50-Day Moving Average of the stock is -12.98%, while the 200-Day Moving Average is calculated to be 5.43%.
Shares Statistics:
It appears that NRIX traded 855.95K shares on average per day over the past three months and 804680 shares per day over the past ten days. A total of 70.84M shares are outstanding, with a floating share count of 68.89M. Insiders hold about 2.74% of the company’s shares, while institutions hold 95.15% stake in the company. Shares short for NRIX as of 1731628800 were 9603933 with a Short Ratio of 11.22, compared to 1728950400 on 9240563. Therefore, it implies a Short% of Shares Outstanding of 9603933 and a Short% of Float of 14.549999999999999.
